- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04998643
Muscle Catabolism and Outcomes in Children Following Cardiac Surgery (MOCHI)
Muscle Catabolism and Its Impact on Functional Outcomes in Children Following Cardiac Surgery
Background & Significance. Children with congenital heart disease (CHD) have experienced improved postoperative survival shifting the focus away from minimizing mortality to curtailing morbidities. Critical illness following cardiac surgery induces catabolism which may impact functional status. Catabolism, a state in which protein breakdown exceeds protein synthesis, can lead to lean body mass (LBM) breakdown. LBM loss has been associated with poor clinical outcomes. Muscle ultrasound (mUS) has been utilized to measure LBM changes and the functional status score (FSS) was developed to assess functional status changes in children following hospitalization. The ability to identify LBM loss acutely and its association with FSS changes may lead to earlier interventions to preserve LBM and aid in outcome prediction.
Specific Aims & Hypotheses. Specific Aim 1 is to identify the percent change in LBM by mUS during the first postoperative week in children following complex cardiac surgery. Specific Aim 2 is to evaluate the relationship between percent change in LBM during the first postoperative week and the FSS at discharge and 6 and 12-month follow-up in children with CHD following complex cardiac surgery. The investigators hypothesize children with CHD following complex cardiac surgery will experience a decline in LBM and that there is a direct relationship between the change in LBM and postoperative FSS follow-up.
Study Design & Methods. The investigators are conducting a single-center, prospective, observational cohort study. Consecutive children (> 3 months and < 18 years of age) with CHD undergoing biventricular conversion will be enrolled. Patients will undergo a baseline mUS and FSS at the time of the index operation. Interval mUS will be obtained on the third and seventh postoperative day. Discharge mUS and FSS will be obtained and a remote FSS will be requested by the family at 6 and 12-months postoperatively. Demographics, pertinent laboratory, concomitant medications, nutrition and ultrasound variables will be collected.
Outcomes. The primary outcomes will be change in LBM during the first postoperative week and change in FSS at 6 and 12-month follow-up in children following complex cardiac surgery. Change in LBM will be defined as a percent change in cross-sectional area of the quadriceps muscle layer thickness (QMLT). Change in FSS will be significant if the score drops 3 points or more from baseline at postoperative follow-up.
Study Overview
Status
Intervention / Treatment
Detailed Description
The central objective of our single center, pilot study in children with CHD following cardiac surgery is to identify serial changes in QMLT, as an estimate of LBM, during the first postoperative week, and to examine its relationship to functional status, assessed by FSS, after hospital discharge.
Primary Aim 1. To measure the percent change in QMLT by mUS during the first postoperative week in children undergoing complex cardiac surgery. The investigators hypothesize children undergoing complex cardiac surgery will have a mean decline of at least 10% in QMLT during the first postoperative week.
Primary Aim 2. To examine the relationship between percent change in QMLT during the first postoperative week and FSS at 3 and 6-months. The investigators hypothesize there is a direct relationship between percent change in QMLT during the first postoperative week and FSS at 3 and 6-months following surgery.
Secondary Aim 1. To explore the relationship between nitrogen balance, defined as the difference between total nitrogen intake and total urinary nitrogen loss, and mean change in QMLT during the first postoperative week. The investigators hypothesize there is a direct correlation between nitrogen balance and mean change in QMLT during the first postoperative week in children following complex cardiac surgery.
The proposed utilization of mUS to measure alterations in body composition during the acute phase of critical illness may provide early prediction of subsequent functional status decline.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kimberly I Mills, MD
- Phone Number: 6173554023
- Email: kimberly.mills@cardio.chboston.org
Study Contact Backup
- Name: Lori Bechard, RD,PhD
- Phone Number: 6173556000
- Email: lori.bechard@childrens.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital
-
Contact:
- Kimberly I Mills, MD
- Phone Number: 617-355-7866
- Email: kimberly.mills@cardio.chboston.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- children > 3 months and < 18 years old,
- diagnosed with CHD, and
- undergoing biventricular conversion.
Exclusion Criteria:
- diagnosis of muscular dystrophy or myopathy,
- lower extremity injury or infection during the current hospitalization,
- enrolled in a concurrent nutritional intervention trial, or
- admitted for palliative care.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in lean body mass
Time Frame: 7 days postoperatively
|
The investigators are measuring the change in lean body mass estimated by quadriceps muscle layer thickness (QMLT)
|
7 days postoperatively
|
Change in functional status
Time Frame: 6 and 12 months
|
The investigators will measure functional status at 6 and 12-month follow-up to investigate the association between change in QMLT and functional status
|
6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Relationship of nitrogen balance to lean body mass changes
Time Frame: 12-24 hours postoperatively
|
The investigators will measure urinary nitrogen balance to investigate its relationship to mean change in QMLT during the first postoperative week
|
12-24 hours postoperatively
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Lori Bechard, RD, PhD, Boston Children's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-P00038896
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease
-
University of UlsterBelfast Health and Social Care TrustCompletedCongenital Heart Disease | Congenital Heart Defect | Adult Congenital Heart DiseaseUnited Kingdom
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Disease CongenitalUnited States
-
Vanderbilt University Medical CenterEnrolling by invitationCongenital Heart Disease | Congenital Heart Defect | Congenital Heart MalformationsUnited States
-
YHAlattarNot yet recruitingCritical Congenital Heart Disease
-
University Hospital TuebingenCompletedComplex Congenital Heart DiseaseGermany
-
The Hospital for Sick ChildrenCompletedCongenital Heart Disease (CHD)Canada
-
University College, LondonSociety for Cardiothoracic Surgery in Great Britain & Ireland; British Congenital...Unknown
-
University of California, DavisCompletedCyanotic Congenital Heart DiseaseUnited States
-
Assistance Publique Hopitaux De MarseilleRecruitingComplex Congenital Heart DiseaseFrance
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); Boston Children's HospitalEnrolling by invitation
Clinical Trials on Muscle ultrasound to estimate lean body mass
-
Karolinska University HospitalUnknown
-
University of JazanCompletedLow Back Pain, MechanicalSaudi Arabia
-
Radboud University Medical CenterCompletedBreast Cancer | Metastatic Castration-resistant Prostate CarcinomaNetherlands
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentCompleted
-
The First Hospital of QinhuangdaoCompletedLaparoscopic Colorectal Surgery | Obese PatientsChina
-
Duke UniversityCompletedCOVID-19United States
-
AHS Cancer Control AlbertaCanadian Institutes of Health Research (CIHR)Unknown
-
Assiut UniversityNot yet recruitingHypertension in PregnancyEgypt
-
University Department of Geriatric Medicine FELIX...Not yet recruitingMuscle Weakness | Frailty | Sarcopenia